AstraZeneca (AZN.L) News and Global Pharmaceutical & Healthcare Updates
14,026
96.00
0.69 %
At close
11/13
GBX
Daily range
13892.00
14064.00
14064.00
Weekly range
13824.00
14184.00
14184.00
FTSE 100 rises on healthcare and energy support, heads for strongest week in a month
London equities are advancing at the end of the week as healthcare and energy stocks lift the FTSE 100 and keep the benchmark on course for its best weekly performance since mid-October. The move ...
Will AstraZeneca stock break higher as new oncology approvals expand market potential?
AstraZeneca (AZN) stock is trading at GBX13,950 after a modest daily rise, with the shares sitting just above their short- and intermediate-term moving averages and ...
AstraZeneca stock consolidates near GBX14,004 resistance as mixed momentum holds
AstraZeneca (AZN) stock is trading at GBX13,885, posting a marginal gain in a quiet session. The current price is sitting below its key short- and medium-term moving ...
AstraZeneca stock price prediction: Range-bound trading persists near GBX13,821 support
AstraZeneca (AZN) stock is trading at GBX13,946, registering a modest decline for the day. The price closed just below its recent session average and sits between key ...
AstraZeneca stock trades flat as buyers defend GBX13,885 support
AstraZeneca (AZN) stock is trading at GBX14,050 after a modest daily increase, closing near the session high. The shares currently sit above their key short- and ...
AstraZeneca stock consolidates near GBX13,885 support as buyer support persists despite mixed signals
AstraZeneca (AZN) stock is trading at GBX13,932 after a modest decline for the day. The price remains above its key moving averages, indicating continued strength over ...
AstraZeneca stock consolidates as price remains near key resistance
AstraZeneca (AZN) stock is trading at GBX14,108 after a modest upward move today. The price remains above its key moving averages, showing resilience in the current ...
AZN climbs as buyer support underpins strong session highs
AstraZeneca (AZN) stock is trading at GBX14,032, posting a daily gain of 1.98%. The price sits above its key moving averages with strong momentum, marking a session near ...
AstraZeneca bid for Rhythm signals push into rare obesity treatments
AstraZeneca is pursuing a potential expansion in obesity and rare disease drugs with an offer of about $10 billion for Rhythm Pharmaceuticals. The approach, reported to have valued Rhythm at about ...
AstraZeneca beats Q3 earnings and reconfirms guidance: AZN consolidates near GBX13,702 support
AstraZeneca (AZN) stock is trading at GBX13,788, posting a modest decline for the session. The current price is situated below its short-term averages, while remaining ...
AstraZeneca reports solid Q3 results despite Farxiga decline: AZN remains range-bound
AstraZeneca (AZN) stock is trading at GBX13,832, showing a modest pullback on the day. The price remains above its key moving averages, signaling a continuation of ...
Can robust earnings and new restructuring support AstraZeneca stock?
AstraZeneca (AZN) stock is trading at GBX13,998, registering a 7.25% gain over the last day. The price currently stands well above its key moving averages, confirming ...
London FTSE 100 heads for first monthly gain in three months as AstraZeneca lifts pharma stocks
UK equities are trading mixed at the end of October, with the FTSE 100 holding onto monthly gains while the midcap index lags. A milder-than-expected tax stance in Finance Minister John Healey's ...
AstraZeneca shares technical analysis: Upward price move as GBX13,252 resistance nears
AstraZeneca (AZN) stock is trading at GBX13,064, up 2.35% for the day. The price is positioned above its key short- and medium-term moving averages, reflecting a ...
AstraZeneca delivers 12 positive Phase III programme readouts as stock rises 2.3%
AstraZeneca announced 12 key positive Phase III programme readouts year-to-date and 47 regulatory approvals in major markets since its Q4 2025 results. The stock is up 2.3% on the day at ...
AstraZeneca launches Meet Your Mark campaign: AZN remains range-bound
AstraZeneca (AZN) stock is trading at GBX12,792, showing a marginal decline for the session. The price action remains subdued, with AZN closing near today's high and ...
AstraZeneca stock holds steady as buyer support persists around GBX12,824 support
AstraZeneca (AZN) stock is trading at GBX12,832, marking a modest decline for the session. The price remains below its key short-term moving averages and is situated ...
AstraZeneca reports positive Phase III cancer drug results: Can AZN sustain momentum?
AstraZeneca (AZN) stock is trading at GBX12,858, closing with a modest gain on the session. The price remains positioned above its key short- and medium-term moving ...
AZN slides as overbought conditions cap upside
AstraZeneca (AZN) stock is trading at GBX12,766, reflecting a decline of 1.65% on the day. The price is positioned above its key short- and medium-term moving averages, ...
Amgen lung cancer combo shows survival gain in late-stage trial
Late-stage trial results suggest Amgen may strengthen Imdelltra's commercial prospects in small cell lung cancer by pairing it with AstraZeneca's Imfinzi. The study shows the combination cuts the ...
Ultomiris and ZEGFROVY approvals lift AstraZeneca stock as buyer support prevails
AstraZeneca (AZN) stock is trading at GBX12,928, up 2.49% for the session. The price is holding above its key short- and medium-term moving averages, reflecting broad ...
